Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/neuros/nyaa265 | DOI Listing |
Dig Liver Dis
January 2025
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea. Electronic address:
Hum Reprod
January 2025
Division of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Aliment Pharmacol Ther
January 2025
Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan.
Oral Oncol
January 2025
Radiation Oncology Unit, REM Radioterapia, 95100 Viagrande, CT, Italy; Department of Medicine and Surgery, University Kore of Enna, 94100 Enna, Italy. Electronic address:
Cancers (Basel)
December 2024
Division of Early Drug Development, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Background: Early-phase clinical trials offer a unique opportunity for patients with cancer. These trials often mandate biopsies to collect tumor tissue for research purposes, requiring patients to undergo invasive procedures. Some trials mandate molecular prescreening, but the success of these analyses relies on the quality and quantity of the tested materials.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!